On voie arrivé l'arriver d'un nouveau PROdrug Lysergamides, courrier reçu du mail officiel des Lézards.
After many months tinkering around in the lab and screaming at black goo in round bottom flasks, we have finally isolated and purified the first commercial batch of our latest legal LSD derivative.
We are very excited to announce the release of 1V-LSD (1-valeroyl-lysergic acid diethylamide hemi-L-tartrate) or simply ‘Valerie’. 1V-LSD is a prodrug of LSD and a homologue of 1P-LSD. Since it is a prodrug, it shares many similar properties with LSD itself but also 1P-LSD, 1cP-LSD, and 1B-LSD. However, Valerie also has some distinguishing features including increased visual effects compared to 1cP-LSD and 1P-LSD, as reported by our research group.
The nickname ‘Valerie’ is derived from segments of the most significant chemical groups described in the chemical name 1-valeroyl-lysergic acid diethylamide. Several participants of our research group also noted the presence of a ‘female entity’ whilst researching this compound. Hence we feel the name Valerie is apt!
1V-LSD is the N-valeroyl derivative of LSD. Due to the high lipophilicity of the valeroyl group there is now a great opportunity to study the potentially unique pharmacokinetic properties of this novel compound.
Valerie was created with global NPS legislations in mind; this beautiful molecule is completely legal in almost all countries, including Germany!
Given that 1V-LSD has a slightly higher mass than other prodrugs, we have decided to increase the dosage of our standard blotters. We will be offering 1V-LSD 150mcg Blotters as our standard product, and in the future introduce pellets, extra dosed blotters, and powder. Based on our tests, 150mcg of 1V-LSD is about equivalent to 125mcg of 1cP-LSD. Therefore, our standard 1V-LSD blotters are stronger than our standard 1cP-LSD blotters — please inform end users accordingly!
We will be formally releasing the product around the 20th July, but we are now accepting pre-orders for quantities of up to 1000 blotters that will be shipped on release. The batch size is currently very small, but production will increase in August.
In order to match the larger dose, as well as an increase in production costs due to crystallisation issues, the wholesale prices of these blotters have increased in comparison to 1cP-LSD or 1P-LSD. The retail prices should increase to reflect this (see retail prices here), but please note that we do hope to drop the wholesale prices in time as the synthesis is optimised.
We are sure Valerie will become a regular tool in the kit of the psychedelic researcher and earn its place amongst its highly praised cousins.
Qu'est ce que vous en pensez vous de tous ça ? Le fait qu'il bataille encore plus vite a l'offre et la demande et au ban récent européen.. C'est des sacrée loustiques en buisness ca y faut le dire !